G-Yoon Im, Ph.D. - Publications

Affiliations: 
2007 University of California, Los Angeles, Los Angeles, CA 
Area:
Biologically Active Compounds

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Im GJ, Chang J, Lee S, Choi J, Jung HH, Lee HM, Ryu SH, Park SK, Kim JH, Kim HJ. Protective role of edaravone against cisplatin-induced ototoxicity in an auditory cell line. Hearing Research. PMID 26278638 DOI: 10.1016/j.heares.2015.08.004  0.321
2015 Lee SH, Kim HS, An YS, Chang J, Choi J, Im GJ. Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells. International Journal of Pediatric Otorhinolaryngology. 79: 58-62. PMID 25434479 DOI: 10.1016/j.ijporl.2014.11.008  0.334
2009 Jung ME, Im GY. Total synthesis of racemic laurenditerpenol, an HIF-1 inhibitor. The Journal of Organic Chemistry. 74: 8739-53. PMID 19863119 DOI: 10.1021/Jo902029X  0.361
2008 Jung ME, Im GYJ. Convergent total synthesis of the racemic HIF-1 inhibitor laurenditerpenol Tetrahedron Letters. 49: 4962-4964. DOI: 10.1016/J.Tetlet.2008.05.116  0.36
Show low-probability matches.